Mackenzie Financial’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-43,920
| Closed | -$29.4K | – | 1615 |
|
|
2024
Q1 | $29.4K | Sell |
43,920
-29,879
| -40% | -$20K | ﹤0.01% | 1497 |
|
|
2023
Q4 | $40.1K | Buy |
73,799
+31,003
| +72% | +$16.8K | ﹤0.01% | 1457 |
|
|
2023
Q3 | $24.5K | Buy |
42,796
+12,228
| +40% | +$6.99K | ﹤0.01% | 1446 |
|
|
2023
Q2 | $41.3K | Buy |
+30,568
| New | +$41.3K | ﹤0.01% | 1469 |
|
|
2022
Q4 | – | Sell |
-90,638
| Closed | -$444K | – | 1565 |
|
|
2022
Q3 | $444K | Buy |
+90,638
| New | +$444K | ﹤0.01% | 967 |
|
|
2021
Q1 | – | Sell |
-18,000
| Closed | -$281K | – | 1187 |
|
|
2020
Q4 | $281K | Sell |
18,000
-65,500
| -78% | -$1.02M | ﹤0.01% | 951 |
|
|
2020
Q3 | $789K | Buy |
+83,500
| New | +$789K | ﹤0.01% | 716 |
|